Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

NRXP holding history

NRX Pharmaceuticals, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NRXP overviewAll 13F holders of NRXPFull Q2 2026 holdings

Shares (Q2 2026)
314,659
Value
$1.29M
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of NRXP by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026314,659$1.29M<0.1%+4,547+1.5%AddedHolders
Q1 2026310,112$660.6K<0.1%+91,246+41.7%AddedHolders
Q4 2025218,866$593.2K<0.1%+33,004+17.8%AddedHolders
Q3 2025185,862$613.5K<0.1%+13,607+7.9%AddedHolders
Q2 2025172,255$561.6K<0.1%+37,598+27.9%AddedHolders
Q1 2025134,657$276.1K<0.1%+60,406+81.4%AddedHolders
Q4 202474,251$163.4K<0.1%−3,090−4.0%ReducedHolders
Q3 202477,341$130.7K<0.1%+11,682+17.8%AddedHolders
Q2 202465,659$160.2K<0.1%−354,295−84.4%ReducedHolders
Q1 2024419,954$198.2K<0.1%+8,032+1.9%AddedHolders
Q4 2023411,922$189.5K<0.1%00.0%UnchangedHolders
Q3 2023411,922$107.1K<0.1%+33,255+8.8%AddedHolders
Q2 2023378,667$183.1K<0.1%00.0%UnchangedHolders
Q1 2023378,667$249.6K<0.1%00.0%UnchangedHolders
Q4 2022378,667$420.0K<0.1%+58,040+18.1%AddedHolders
Q3 2022320,627$237.0K<0.1%+12,195+4.0%AddedHolders
Q2 2022308,432$185.0K<0.1%+14,565+5.0%AddedHolders
Q1 2022293,867$719.0K<0.1%+82,367+38.9%AddedHolders
Q4 2021211,500$1.01M<0.1%+165,734+362.1%AddedHolders
Q3 202145,766$424.0K<0.1%+11,291+32.8%AddedHolders
Q2 202134,475$400.0K<0.1%+34,475NewHolders